Figure 3

Histograms of DNA content of A549 (A–C) and Calu-6 (D–F) cells demonstrating the accumulation of cells in the S phase after topotecan treatment (B and E), and the minimal increase in the G1 phase after gemcitabine exposure (C and F) with respect to controls (A and D).